Business

CCM Research Issues Update Report on Biorem Inc.

CCM Research Issues Update Report on Biorem Inc.

articleBiorem Inc.May 13, 20093/company/biorem-inc/news/ccm-research-issues-update-report-on-biorem-inc
CCM Research Issues Update Report on Biorem Inc.

About this update from Biorem Inc.

[{"type":"text","content":"\nCCM Research Issues Update Report on Biorem Inc.\n\n\n May 13, 2009 (Filing Services Canada) -- Biorem Inc. (BRM - TSX Venture), manufactures Biosorbens(r) biofilter media and is a leading supplier of biofilters and biotrickling for air pollution control in municipal and industrial applications, including BIOCUBE(r) modular units and Mytilus(r) biotrickling filters. With over 600 installed systems and over a decade of experience, the Company's products are the technology of choice for odor control at wastewater treatment plants across North America. Additional information on BIOREM(r) is also available at www.biorem.biz. In the report the analyst states, \"Biorem Inc. (BRM.V) is executing on a well thought out strategy resulting in significant top line growth, an increasing installed base, and, in its two most recent quarters, a net profit.\"The analyst continues, \"The Company recently completed its first XLD-based system at a municipal wastewater treatment facility. The XLD system has successfully removed over 99% of all hydrogen Sulfide from the treated airstreams. Additionally, the company opened a sales office in China during Q4 2008. The current stock price target is $0.80.\"A free copy of the report can be found at: http://www.baystreet.ca/articles/research_reports/ccm_research/BRM_Update_Report_May_12_2009.pdfCCM Research is a division of Cronus Capital Markets, Inc. Cronus Capital Markets, Inc., through its CCM Corporate Advisory division, entered into a contract with the Company to assist it with the creation and execution of information-based strategies to overcome market inefficiencies that are commonplace for the vast majority of public companies, including: share illiquidity, lack of credibility, and stagnant market capitalization.Cronus Capital Markets(r) (CCM) is a leading capital market services firm providing services to investors, institutions, exchanges, and public companies. CCM's equity research, indexes, and ETFs receive international attention and represent important new sectors of growth.The TSX Venture Exchange has neither approved nor disapproved the contents of the press release.SOURCE: Cronus Capital MarketsPeter SoniDirector of ResearchT: 416-368-3700 ext 225E: [email protected] CAPITAL MARKETS, INC. IS THE SOLE SOURCE OF THIS PRESS RELEASEMaximum News Dissemination by Filing Se...

More updates from Biorem Inc.